Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
- PMID: 32314704
- PMCID: PMC7253113
- DOI: 10.4269/ajtmh.20-0271
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
Comment on
-
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3. Antiviral Res. 2020. PMID: 32251768 Free PMC article.
References
-
- Omura S, Crump A, 2014. Ivermectin: panacea for resource-poor communities? Trends Parasitol 30: 445–455. - PubMed
-
- Tay MY, Fraser JE, Chan WK, Moreland NJ, Rathore AP, Wang C. Vasudevan SG, Jans DA, 2013. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Antiviral Res 99: 301–306. - PubMed
-
- Yang SNY, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, Borg NA, Jans DA, 2020. The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta1 heterodimer. Antiviral Res 177: 104760. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical